I. I. Asinovskova

I. I. Asinovskova

Auto-generated profile, based on publicly available information

I. I. Asinovskova

Krasnov Research Institute of Eye Diseases

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 December 2023 in National Journal glaucoma
Verified
Journal Article
Open access
PDF file
AVA. A. Vitkov
A. A. Vitkov
AKA. V. Kuroyedov
A. V. Kuroyedov
AMA. S. Makarova
A. S. Makarova
RPR. P. Poleva
R. P. Poleva
DDD. A. Dorofeev
D. A. Dorofeev
IAI. I. Asinovskova
I. I. Asinovskova
Glaucoma surgery is the most effective way to achieve target levels of intraocular pressure. However, it has significant advantages and disadvantages. The main disadvantage is the temporary nature of its hypotensive effect. The onset of surgical failure can occur at various times after the intervention. A correct assessment of the operation timing and risk factors for excessive scarring, as well as correct perioperative therapy, can prolong the effectiveness of the surgery and reduce the number of repeat operations.With a wide choice of surgical treatment methods, trabeculectomy remains the most frequently performed intervention. Its effect is better understood and can be considered more controllable. If the surgical treatment of glaucoma is ineffective, it is possible to prescribe a "restart" therapy, activate previously formed outflow tracts, and perform a second intervention. The development of needling technology makes it possible to delay repeat interventions, prolonging the hypotensive effect of the initial operation.

12 May 2023 in National Journal glaucoma
Verified
Journal Article
Open access
PDF file
AVA. A. Vitkov
A. A. Vitkov
KHKh. Hadiri
Kh. Hadiri
TAT. M. Aghajanyan
T. M. Aghajanyan
AAA. M. Akimov
A. M. Akimov
IAI. I. Asinovskova
I. I. Asinovskova
ХХХ. Хдери
Х. Хдери
Purpose of this study — to compare the results of different tonometry methods before surgical treatment of glaucoma and in the early postoperative period.The study was conducted on a group of 50 patients (50 eyes) aged 55 to 80 years with uncompensated primary open-angle glaucoma, who were admitted to in-patient department for glaucoma surgery. Patients were examined using bidirectional applanation tonometry of the cornea performed on Ocular Response Analyzer, pneumotonometry on Canon TX-20P device, and with Icare tonometer. These studies were carried out on the day before the surgery, the next day, and 2 weeks after the operation.Significant differences in tonometry readings were revealed between all tested devices at high intraocular pressure (IOP) levels (before glaucoma surgery). Significant differences were also found in IOP values obtained with Icare tonometer in the central zone of the cornea and in the middle periphery in the nasal and temporal sectors. A significant difference between the indicators remained on the next day after surgery, except for the Icare readings. After two weeks, the tonometric parameters did not differ significantly from each other.Corneal compensated IOP (IOPcc) is the most important tonometric indicator in clinical practice because it takes into account the individual biomechanical characteristics of the patient’s cornea. When examining patients with glaucoma, the IOPcc indicator significantly differed in uncompensated IOP, which is important for determining the correct treatment tactics. When assessing the level of IOP after surgery this trend persisted, indicating a systematic underestimation of IOP level (overestimation of the effect of glaucoma surgery). The reliability of the study is confirmed by the results of measurements on unoperated fellow eyes (control).

13 September 2025 in National Journal glaucoma
Verified
Journal Article
Open access
PDF file
YYYu. Yusef
Yu. Yusef
АAА. А. Antonov
А. А. Antonov
ASAnastasia Subbot
Anastasia Subbot
IVI. I. Vitkova
I. I. Vitkova
EEElizaveta Emets
Elizaveta Emets
ЮЮЮ. Юсеф
Ю. Юсеф
The main complication of glaucoma surgery is excessive scarring of newly created aqueous humor outflow pathways. To prevent fibrotic tissue formation, medications with different mechanisms of action are used intraoperatively and during the early postoperative period.The primary group of anti-inflammatory drugs used in glaucoma surgery are topical steroids. A particularly high antiinflammatory efficacy has been demonstrated with a slowrelease dexamethasone implant placed under the scleral flap.Nonsteroidal anti-inflammatory drugs, in addition to their direct effect, can potentiate the hypotensive action of prostaglandin analogs and reduce the severity of their local side effects. The use of antimetabolites such as mitomycin C and 5-fluorouracil is justified by their antifibrotic activity, which inhibits DNA synthesis and, consequently, the proliferation of cells including myofibroblasts. However, they are associated with a high risk of hypotonic complications. Angiogenesis inhibitors suppress vascular endothelial growth factor production and thus block proliferation.The use of ranibizumab, bevacizumab, and infliximab as adjuncts to standard therapy can enhance the longterm effectiveness of glaucoma surgery. However, their use remains limited and not fully explored.

27 May 2025 in National Journal glaucoma
Verified
Journal Article
Open access
PDF file
YYYu. N. Yusef
Yu. N. Yusef
АAА. А. Antonov
А. А. Antonov
ASAnastasia Subbot
Anastasia Subbot
IVI. I. Vitkova
I. I. Vitkova
EEElizaveta Emets
Elizaveta Emets
ЮЮЮ. Н. Юсеф
Ю. Н. Юсеф
The main complication of glaucoma surgery is cicatricial changes in newly formed outflow tracts. This process leads to a repeated increase in intraocular pressure (IOP) and is the reason for a decrease in the effectiveness of glaucoma surgeries. In the cascade of successive stages of surgical wound healing, the inflammation phase is considered the most important. Reducing its severity and duration is the main goal of postoperative therapy, since excessive inflammation leads to the formation of scar tissues. In turn, its excessive suppression leads to the development of "ineffective resolution". In this case, the inflammation becomes chronic, and the next healing phase does not occur. For complete restoration of the damaged tissue architecture, the healing process must consistently go through all phases. The use of pro-resolving mediators can contribute to the correct completion of inflammation.This review explores the physiological processes of restoration of the damaged tissue architecture, as well as the causes of cicatricial changes in the newly formed intraocular fluid outflow tracts.

3 December 2024 in The EYE GLAZ
Verified
Journal Article
Closed access
PDF file
AAA. A. Antonov
A. A. Antonov
AVA. A. Vitkov
A. A. Vitkov
AMA. S. Makarova
A. S. Makarova
RPR. P. Poleva
R. P. Poleva
IVI. I. Vitkova
I. I. Vitkova
Introduction. One limitation of glaucoma surgery is its reduced long-term effectiveness due to scarring of intraocular fluid outflow pathways. Appropriate perioperative therapy may extend the hypotensive effect by reducing scarring and improving the filtration bleb. Purpose: to evaluate the effect of perioperative use of Oku-Oku® on intraocular pressure (IOP) and filtration bleb condition in the early postoperative period following glaucoma surgery. Materials and methods. Thirty patients (30 eyes) who underwent non-penetrating glaucoma surgery (NPGS) were studied. The main group (15 eyes) received Oku-Oku® drops twice daily: the day before surgery, immediately before surgery, and for five days postoperatively. The control group (15 eyes) received no additional medication. Tonometry and assessment of conjunctival hyperemia were performed the day before surgery, and at 1 day, 2 weeks, and 1 month postoperatively. Filtration bleb characteristics were assessed using the Würzburg Clinical and Morphological Classification of Filtration Pads at the same time points, except for the preoperative assessment. Results. Glaucoma surgery significantly reduced IOP in both groups. After 1 month, the mean IOP in the main group was lower (15.1 ± 4.1 mm Hg) compared to the control group (17.9 ± 3.3 mm Hg). Conjunctival hyperemia was also lower in the main group (15.4 ± 2.7%) than in the control group (18.0 ± 3.1%). Filtration bleb parameters improved in both groups over time, with the greatest differences observed at 1 day and 2 weeks post-surgery. Conclusion. Perioperative use of Oku-Oku® reduced conjunctival hyperemia in the filtration bleb area during the first month after glaucoma surgery. This early improvement in the intraocular fluid deposition area may enhance the effectiveness of glaucoma surgery. Oku-Oku® can be used in comprehensive preparation for glaucoma surgery and other similar anterior segment procedures.

23 April 2024 in Russian Annals of Ophthalmology
Verified
Journal Article
Closed access
VEV.P. Erichev
V.P. Erichev
AVA.A. Vitkov
A.A. Vitkov
AAA.A. Antonov
A.A. Antonov
IAI.I. Asinovskova
I.I. Asinovskova
RPR.P. Poleva
R.P. Poleva
Purpose. This study analyzes changes in light sensitivity in each test point of the visual field in patients with different stages of glaucoma. Material and methods. The data of a prospective analytical case-control study were analyzed. All patients underwent assessment of retinal light sensitivity and its variability in 54 points corresponding to the 24-2 program. Mean light sensitivity values were calculated in each point. Intergroup analysis was performed to evaluate changes in light sensitivity in each point. Results. The range of light sensitivity decrease in the early glaucoma group compared to the control group was from 1.5 to 3.6 dB. The range of light sensitivity decrease in the moderate glaucoma group compared to the control group was from 2.1 to 11.5 dB, and compared to the early glaucoma group — from –0.9 to 7.9 dB. The most frequent decrease in light sensitivity was detected in the nasal sector and along the horizontal line in the upper half of the visual field. This trend persisted within the central 10 degrees of the visual field. The range of light sensitivity decrease in the advanced glaucoma group compared to the control group was from 14.1 to 28.0 dB, and compared to the early glaucoma group — from 11.35 to 26.08 dB, compared to the moderate glaucoma group — from 9.1 to 23.5 dB. The most frequent and severe decrease in light sensitivity was detected in the paracentral zone in the lower half of the visual field. Conclusion. The study analyzed the trends in the development of glaucoma from the early to the advanced stage. The most frequent and severe defect in light sensitivity in cases of verified advanced glaucoma was found in the lower half of the visual field. Points No. 32, 33 and 40 can be indicated as the area of interest in assessing the progression of glaucoma, as they were found to have the most profound changes in light sensitivity as glaucoma progressed.